Egetis Therapeutics AB announced that Yilmaz Mahshid, PhD, has been appointed as Chief Financial Officer (CFO), joining in the second quarter of 2021. He will be part of the company's management team and report to the CEO. Yilmaz has experience from different senior positions in the life science sector, including Investment Manager & Controller at Industrifonden, and CFO at PledPharma between 2017 and 2020, as well as healthcare analyst at Pareto Securities and Öhman Fondkommission. Prior to joining Egetis Therapeutics, Yilmaz was CEO of the Medivir.